Transient Elastography-based Risk Estimation of Hepatitis B Virus-related Occurrence of Hepatocellular Carcinoma: Development and Validation of a Predictive Model
Overview
Authors
Affiliations
Background: The purpose of this study was to develop and validate a novel transient elastography-based predictive model for occurrence of hepatocellular carcinoma (HCC).
Methods: A total of 1,250 patients with chronic hepatitis B and baseline liver stiffness values were recruited between May 2005 and December 2007. The predictive model for HCC occurrence was constructed based on a Cox proportional hazards model. We estimated baseline disease-free probabilities at 3 years. Discrimination and calibration were used to validate the model.
Results: HCC occurred in 56 patients during a median follow-up of 30.7 months. Multivariate analysis revealed that age, male gender, and liver stiffness values were independent predictors of HCC (all P<0.05), whereas hepatitis B virus DNA ≥20,000 IU/L showed borderline statistical significance (P=0.0659). We developed a predictive model for HCC using these four variables, which showed good discrimination capability, with an area under the receiver operating characteristic curve (AUROC) of 0.806 (95% confidence interval 0.738-0.874). We used the bootstrap method to assess discrimination. The AUROC remained largely unchanged between iterations, with an average value of 0.802 (95% confidence interval 0.791-0.812). The predicted risk of occurrence of HCC calibrated well with the observed risk, with a correlation coefficient of 0.905 (P<0.001).
Conclusion: This novel model accurately estimated the risk of HCC occurrence in patients with chronic hepatitis B.
Cong X, Song S, Li Y, Song K, MacLeod C, Cheng Y BMC Med. 2024; 22(1):601.
PMID: 39736748 PMC: 11686935. DOI: 10.1186/s12916-024-03754-9.
Kim M, Han J, An J, Kim B, Jin Y, Kim S Clin Mol Hepatol. 2024; 30(Suppl):S5-S105.
PMID: 39159947 PMC: 11493350. DOI: 10.3350/cmh.2024.0506.
Hao X, Fan R, Zeng H, Hou J J Clin Transl Hepatol. 2024; 11(7):1508-1519.
PMID: 38161501 PMC: 10752803. DOI: 10.14218/JCTH.2023.00087.
Yu J, Cho S, Jin Y, Lee J Clin Mol Hepatol. 2021; 28(3):351-361.
PMID: 34823308 PMC: 9293610. DOI: 10.3350/cmh.2021.0281.
Screening for Hepatocellular Carcinoma in Chronic Hepatitis B: An Update.
Lok J, Agarwal K Viruses. 2021; 13(7).
PMID: 34372539 PMC: 8309969. DOI: 10.3390/v13071333.